These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 18321866)
1. Stoichiometric imbalance in the receptor complex contributes to dysfunctional BMPR-II mediated signalling in pulmonary arterial hypertension. Nasim MT; Ghouri A; Patel B; James V; Rudarakanchana N; Morrell NW; Trembath RC Hum Mol Genet; 2008 Jun; 17(11):1683-94. PubMed ID: 18321866 [TBL] [Abstract][Full Text] [Related]
2. Mutations of the TGF-beta type II receptor BMPR2 in pulmonary arterial hypertension. Machado RD; Aldred MA; James V; Harrison RE; Patel B; Schwalbe EC; Gruenig E; Janssen B; Koehler R; Seeger W; Eickelberg O; Olschewski H; Elliott CG; Glissmeyer E; Carlquist J; Kim M; Torbicki A; Fijalkowska A; Szewczyk G; Parma J; Abramowicz MJ; Galie N; Morisaki H; Kyotani S; Nakanishi N; Morisaki T; Humbert M; Simonneau G; Sitbon O; Soubrier F; Coulet F; Morrell NW; Trembath RC Hum Mutat; 2006 Feb; 27(2):121-32. PubMed ID: 16429395 [TBL] [Abstract][Full Text] [Related]
3. Mutations in bone morphogenetic protein type II receptor cause dysregulation of Id gene expression in pulmonary artery smooth muscle cells: implications for familial pulmonary arterial hypertension. Yang J; Davies RJ; Southwood M; Long L; Yang X; Sobolewski A; Upton PD; Trembath RC; Morrell NW Circ Res; 2008 May; 102(10):1212-21. PubMed ID: 18436795 [TBL] [Abstract][Full Text] [Related]
4. Functional interaction between BMPR-II and Tctex-1, a light chain of Dynein, is isoform-specific and disrupted by mutations underlying primary pulmonary hypertension. Machado RD; Rudarakanchana N; Atkinson C; Flanagan JA; Harrison R; Morrell NW; Trembath RC Hum Mol Genet; 2003 Dec; 12(24):3277-86. PubMed ID: 14583445 [TBL] [Abstract][Full Text] [Related]
5. Receptor for activated C-kinase 1, a novel interaction partner of type II bone morphogenetic protein receptor, regulates smooth muscle cell proliferation in pulmonary arterial hypertension. Zakrzewicz A; Hecker M; Marsh LM; Kwapiszewska G; Nejman B; Long L; Seeger W; Schermuly RT; Morrell NW; Morty RE; Eickelberg O Circulation; 2007 Jun; 115(23):2957-68. PubMed ID: 17515463 [TBL] [Abstract][Full Text] [Related]
6. HIV-1 TAT represses transcription of the bone morphogenic protein receptor-2 in U937 monocytic cells. Caldwell RL; Gadipatti R; Lane KB; Shepherd VL J Leukoc Biol; 2006 Jan; 79(1):192-201. PubMed ID: 16282533 [TBL] [Abstract][Full Text] [Related]
7. Bone morphogenetic protein receptor type II C-terminus interacts with c-Src: implication for a role in pulmonary arterial hypertension. Wong WK; Knowles JA; Morse JH Am J Respir Cell Mol Biol; 2005 Nov; 33(5):438-46. PubMed ID: 16002577 [TBL] [Abstract][Full Text] [Related]
8. Failure of bone morphogenetic protein receptor trafficking in pulmonary arterial hypertension: potential for rescue. Sobolewski A; Rudarakanchana N; Upton PD; Yang J; Crilley TK; Trembath RC; Morrell NW Hum Mol Genet; 2008 Oct; 17(20):3180-90. PubMed ID: 18647753 [TBL] [Abstract][Full Text] [Related]
9. Signaling molecules in nonfamilial pulmonary hypertension. Du L; Sullivan CC; Chu D; Cho AJ; Kido M; Wolf PL; Yuan JX; Deutsch R; Jamieson SW; Thistlethwaite PA N Engl J Med; 2003 Feb; 348(6):500-9. PubMed ID: 12571257 [TBL] [Abstract][Full Text] [Related]
10. Correction of nonsense BMPR2 and SMAD9 mutations by ataluren in pulmonary arterial hypertension. Drake KM; Dunmore BJ; McNelly LN; Morrell NW; Aldred MA Am J Respir Cell Mol Biol; 2013 Sep; 49(3):403-9. PubMed ID: 23590310 [TBL] [Abstract][Full Text] [Related]
13. Characterization of the BMPR2 5'-untranslated region and a novel mutation in pulmonary hypertension. Aldred MA; Machado RD; James V; Morrell NW; Trembath RC Am J Respir Crit Care Med; 2007 Oct; 176(8):819-24. PubMed ID: 17641158 [TBL] [Abstract][Full Text] [Related]
14. Serotonin increases susceptibility to pulmonary hypertension in BMPR2-deficient mice. Long L; MacLean MR; Jeffery TK; Morecroft I; Yang X; Rudarakanchana N; Southwood M; James V; Trembath RC; Morrell NW Circ Res; 2006 Mar; 98(6):818-27. PubMed ID: 16497988 [TBL] [Abstract][Full Text] [Related]
15. [Analysis of genetic mutation and modifier genes in pulmonary arterial hypertension]. Fujiwara M; Yagi H; Matsuoka R; Saji T Nihon Rinsho; 2008 Nov; 66(11):2071-5. PubMed ID: 19051722 [TBL] [Abstract][Full Text] [Related]
18. Genetics of pulmonary arterial hypertension: current and future implications. Elliott CG Semin Respir Crit Care Med; 2005 Aug; 26(4):365-71. PubMed ID: 16121312 [TBL] [Abstract][Full Text] [Related]
19. Role of apoptosis in pulmonary hypertension: from experimental models to clinical trials. Jurasz P; Courtman D; Babaie S; Stewart DJ Pharmacol Ther; 2010 Apr; 126(1):1-8. PubMed ID: 20117135 [TBL] [Abstract][Full Text] [Related]